Cowen Starts Ocular Therapeutix (OCUL) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Fiserv president resigns, interim leaders named for financial unit
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
UPDATE: RBC Capital Starts Ocular Therapeutix (OCUL) at Outperform
August 19, 2014 6:46 AM EDT(Updated - August 19, 2014 6:59 AM EDT)
RBC Capital initiated coverage on Ocular Therapeutix (NASDAQ: OCUL) with an Outperform rating and a price target of $21.00.
Analyst Adnan Butt said, "We believe OCUL shares offer the potential for upside as the hydrogel, sustained technology platform... More
Oppenheimer Starts Ocular Therapeutix (OCUL) at Outperform
August 19, 2014 6:46 AM EDTOppenheimer initiated coverage on Ocular Therapeutix (NASDAQ: OCUL) with an Outperform rating and a price target of $25.00.
For an analyst ratings summary and ratings history on Ocular Therapeutix click here. For more ratings news on Ocular Therapeutix click here.
Shares of Ocular Therapeutix closed at $14.33 yesterday.
... More